These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25047500)

  • 41. Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer.
    Eilertsen KJ; Power RA; Harkins LL; Misica P
    Anim Reprod Sci; 2007 Mar; 98(1-2):129-46. PubMed ID: 17166676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
    Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
    Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early epigenetic cancer decisions.
    Martín-Lorenzo A; Gonzalez-Herrero I; Rodríguez-Hernández G; García-Ramírez I; Vicente-Dueñas C; Sánchez-García I
    Biol Chem; 2014 Nov; 395(11):1315-20. PubMed ID: 25205718
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Common themes of dedifferentiation in somatic cell reprogramming and cancer.
    Daley GQ
    Cold Spring Harb Symp Quant Biol; 2008; 73():171-4. PubMed ID: 19150965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells.
    Scaffidi P; Misteli T
    Cold Spring Harb Symp Quant Biol; 2010; 75():251-8. PubMed ID: 21047903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concise Review: Induced Pluripotent Stem Cells as New Model Systems in Oncology.
    Laplane L; Beke A; Vainchenker W; Solary E
    Stem Cells; 2015 Oct; 33(10):2887-92. PubMed ID: 26179060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance.
    Fatma H; Maurya SK; Siddique HR
    Semin Cancer Biol; 2022 Aug; 83():166-176. PubMed ID: 33220458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induced Pluripotent Stem Cells from Cancer-Resistant Naked Mole-Rats.
    Miura K; Oiwa Y; Kawamura Y
    Adv Exp Med Biol; 2021; 1319():329-339. PubMed ID: 34424523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Telomere rejuvenation during nuclear reprogramming.
    Marión RM; Blasco MA
    Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic memory in the context of nuclear reprogramming and cancer.
    Halley-Stott RP; Gurdon JB
    Brief Funct Genomics; 2013 May; 12(3):164-73. PubMed ID: 23585580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cellular reprogramming technology for dissecting cancer epigenome in vivo.
    Ito K; Yamada Y
    Epigenomics; 2017 Jul; 9(7):997-1011. PubMed ID: 28651445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erase and Rewind: Epigenetic Conversion of Cell Fate.
    Pennarossa G; Zenobi A; Gandolfi CE; Manzoni EF; Gandolfi F; Brevini TA
    Stem Cell Rev Rep; 2016 Apr; 12(2):163-70. PubMed ID: 26589198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Aging Strategies Based on Cellular Reprogramming.
    Ocampo A; Reddy P; Belmonte JCI
    Trends Mol Med; 2016 Aug; 22(8):725-738. PubMed ID: 27426043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotype switching through epigenetic conversion.
    Brevini TA; Pennarossa G; Maffei S; Gandolfi F
    Reprod Fertil Dev; 2015 Jun; 27(5):776-83. PubMed ID: 25739562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rejuvenation by Partial Reprogramming of the Epigenome.
    Mendelsohn AR; Larrick JW; Lei JL
    Rejuvenation Res; 2017 Apr; 20(2):146-150. PubMed ID: 28314379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
    Hotta A; Ellis J
    J Cell Biochem; 2008 Nov; 105(4):940-8. PubMed ID: 18773452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.